scholarly journals Policy addressing suicidality in children and young people: a scoping review protocol

BMJ Open ◽  
2018 ◽  
Vol 8 (9) ◽  
pp. e023153 ◽  
Author(s):  
Lynne Gilmour ◽  
Edward Duncan ◽  
Margaret Maxwell
Keyword(s):  
Public Health ◽  
Young People ◽  
Scoping Review ◽  
Best Practice ◽  
Data Extraction ◽  
Health Issue ◽  
Public Health Issue ◽  
Policy Documents ◽  
Children And Young People ◽  
Mesh Terms

IntroductionSuicide is one of the leading causes of death among children and young people globally and a major public health issue. Government policies determine how much recognised health issues are prioritised and set the context for investment, development and delivery of services. A review of policies concerning children and young people who are suicidal could shed light on the extent that this public health issue is prioritised and highlight examples of best practice in this area. There has never been a review to explore how policy worldwide addresses the specific needs of this vulnerable population. This review will map the key policy documents and identify their relevance to the review question: how does policy address the treatment and care of children and young people who experience suicidality? (international, national (UK) and local (Scotland)).MethodologyEmploying scoping review methodological guidance a systematic and transparent approach will be taken. Preliminary searches will facilitate the identification of MeSh terms, subject headings, individual database and platform nuances. A full search strategy will be created to search five databases: CINAHL, PsychInfo, Medline, Web of Science and Cochrane. Government and other key agency websites (eg, WHO, Unicef) will be searched to identify policy documents. The reference lists of identified documents will be checked. A second reviewer will independently screen and cross validate eligible studies for final inclusion. A data extraction template will then be used to extract key information. We will report our findings using narrative synthesis and tabulate findings, by agreed key components.Ethics and disseminationEthical approval is not required to conduct a scoping review. We will disseminate the findings through a peer-reviewed publication and conference presentation.

scholarly journals Policy addressing suicidality in children and young people: an international scoping review

BMJ Open ◽  
2019 ◽  
Vol 9 (10) ◽  
pp. e030699 ◽  
Author(s):  
Lynne Gilmour ◽  
Margaret Maxwell ◽  
Edward Duncan
Keyword(s):  
Young People ◽  
Scoping Review ◽  
Grey Literature ◽  
Specific Reference ◽  
Health Practitioner ◽  
Care Needs ◽  
Policy Documents ◽  
Children And Young People ◽  
National Guidance ◽  
Key Policy

ObjectiveTo map key policy documents worldwide and establish how they address the treatment and care needs of children and young people (CYP) who are suicidal.DesignWe conducted a scoping review to systematically identify relevant key policy documents following a pre-established published protocol.Data sourcesFour databases (CINAHL; Medline; PsycINFO; The Cochrane Database of Systematic reviews) and the websites of key government, statutory and non-statutory agencies were searched. Google and Google Scholar were used to identify other policy documents and relevant grey literature. Leading experts were consulted by email.Eligibility criteria for selected studiesPolicies, policy guidance, strategies, codes of conduct, national service frameworks, national practice guidance, white and green papers, and reviews of policy—concerned with indicated suicide prevention approaches for children up to 18 years old. Limited by English language and published after 2000.Data extraction and synthesisData were extracted using a predetermined template. Second reviewers independently extracted 25%. Documents were categorised as international guidance, national policy and national guidance, and presented in a table providing a brief description of the policy, alongside how it specifically addresses suicidal CYP. Findings were further expressed using narrative synthesis.Results35 policy documents were included in the review. Although many recognise CYP as being a high-risk or priority population, most do not explicitly address suicidal CYP. In general, national guidance documents were found to convey that suicidal children should be assessed by a child and adolescent mental health practitioner but offer no clear recommendations beyond this.ConclusionThe lack of specific reference within policy documents to the treatment and care of needs of children who are suicidal highlights a potential gap in policy that could lead to the needs of suicidal children being overlooked, and varying interpretations of appropriate responses and service provision.

scholarly journals How Inhaler Technique is Assessed in Children and Young People: A Scoping Review Protocol

2021 ◽  
Author(s):  
Kathryn Claire Anne Ferris ◽  
Paddy McCrossan ◽  
Michael D Shields ◽  
James Paton ◽  
Dara O’Donoghue
Keyword(s):  
Young People ◽  
Scoping Review ◽  
Data Extraction ◽  
Open Science ◽  
Cochrane Library ◽  
Inhaler Technique ◽  
Case Control Studies ◽  
Children And Young People ◽  
Randomised Control Trials ◽  
Science Framework

Abstract BackgroundAsthma is the most common chronic childhood condition. Unfortunately, many children have poorly controlled asthma. Current guidelines strongly recommend that all asthma review appointments must include an assessment of the patient’s inhaler technique. However, most guidelines do not provide information on how the healthcare professional should conduct this assessment. The aim of this scoping review is to explore the published literature on methods used to assess inhaler technique. MethodsThis scoping review will follow the frameworks founded by Arksey and O’Malley and the Joanna Briggs Institute guidelines. We will search MEDLINE, Embase, Cinahl and the Cochrane library for studies published from 1st January 1956 to 30th November 2021, on methods of assessing inhaler technique in children and young people aged 1 to 16 years of age with asthma. We will include randomised control trials, case control studies, cohort studies and retrospective studies which investigate methods used to assess inhaler technique in children and young people. We will include studies conducted in all areas where inhaler technique assessment occurs and studies conducted by all healthcare professionals who usually undertake inhaler assessments in practice. Two reviewers will complete all screening and data extraction independently. Data will be extracted onto a charting table and a descriptive summary of the results presented. DiscussionThis scoping review will provide a broad overview of currently used methods to assess inhaler technique in children and young people with asthma. The analysis of which will allow us to consider how these methods might be used in clinical practice and research settings. Scoping review registration Open Science Framework (osf.io/e47sa).

Identifying changes in trends in the age standardized incidence of melanoma in Australia

2019 ◽  
Vol 3 (4) ◽  
pp. 250-252 ◽  
Author(s):  
David M Hille
Keyword(s):  
Public Health ◽  
Linear Regression ◽  
Iterative Process ◽  
Linear Trend ◽  
Piecewise Linear ◽  
Health Issue ◽  
Public Health Issue ◽  
Piecewise Linear Regression ◽  
Significant Public Health ◽  
Males And Females

ObjectiveTo identify changes in the linear trend of the age-standardized incidence of melanoma in Australia for all persons, males, and females. MethodsA two-piece piecewise linear regression was fitted to the data. The piecewise breakpoint varied through an iterative process to determine the model that best fits the data.ResultsStatistically significant changes in the trendof the age-standardized incidence of melanoma in Australia were found for all persons, males, and females. The optimal breakpoint for all persons and males was at 1998. For females, the optimal breakpoint was at 2005. The trend after these breakpoints was flatter than prior to the breakpoints, but still positive.ConclusionMelanoma is a significant public health issue in Australia. Overall incidence continues to increase. However, the rate at which the incidence is increasing appears to be decreasing.

The Other View of Disposable Diapers

PEDIATRICS ◽  
1992 ◽  
Vol 89 (2) ◽  
pp. 350-351
Author(s):  
ROBERT L. CAMPBELL
Keyword(s):  
Public Health ◽  
Solid Wastes ◽  
Health Hazards ◽  
The Other ◽  
Health Issue ◽  
Public Health Issue ◽  
Public Health Hazards ◽  
Disposable Diapers

To The Editor.— I'm writing to you to express my extreme disappointment at the publication of the commentary titled "Baby Bottoms and Environmental Conundrums: Disposable Diapers and the Pediatrician" that appeared in the August 1991 issue of Pediatrics.1 Public Health Issue About Diaper Disposal. The authors have treated briefly the issue of public health and diaper disposal.1,p387 The reader is left with a perception that discarded diapers pose public health hazards. While the issue of public health and the disposal of diapers and other solid wastes is important, it is treated neither adequately nor fairly in this commentary.

Regulatory frameworks for clinical trial data sharing during the Pandemic and beyond: A scoping review (Preprint)

2021 ◽  
Author(s):  
Nachiket Gudi ◽  
Prashanthi Kamath ◽  
Trishnika Chakraborty ◽  
Anil G. Jacob ◽  
Shradha Parsekar ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Data Sharing ◽  
Scoping Review ◽  
Data Extraction ◽  
Grey Literature ◽  
Clinical Trial Data ◽  
Trial Data ◽  
Policy Documents ◽  
Regulatory Documents ◽  
Share Data

BACKGROUND Data sharing from clinical trials is well recognized and has widely gained recognition amid the COVID-19 pandemic. The competing interests of powerful stakeholders expressed through data exclusivity practices make clinical trial data sharing a complex phenomenon. The wider acceptance of data sharing practices in the absence of mandated policy creates uncertainty among trial investigators to count for risks vs benefit from sharing trial data. Data sharing becomes further complex as the trial data sharing is governed by the regional policies. This drew our attention to explore policies for informed data sharing. OBJECTIVE This scoping review aimed to map the existing literature around the regulatory documents that guide trial investigators to share clinical trial data. METHODS We followed a Joanna Briggs Institute scoping review approach and have reported the article according to the PRISMA extension for Scoping reviews (PRISMA-ScR). In addition to the use of the electronic databases, a targeted website search was performed to access relevant grey literature. The articles were screened at the title-abstract and the full text stages based on the selection criteria. All the included articles for data extraction were in English language. Data extraction was done independently using a pre-tested data extraction sheet. Included literature focused on clinical trial data sharing policies, guidelines, or SOPs. A narrative synthesis approach was used to summarize the findings. RESULTS This scoping review identified four articles and 13 policy documents from the grey literature. A majority of the clinical trial agencies require an agreement for data sharing between the data requestor/organization and trial agency. None of the policy documents mandates informed consent for data sharing. The time interval to share data underlying results, varies from six to 18 months from the time of trial publication. Depending upon trial data, policies follow both controlled and open access models. Regulatory documents identified in both scientific and grey literature emphasized on good research principles of protection of privacy of participant data and data anonymization through data sharing agreement between the data requester and trial agency. Need for an informed consent and cost of data sharing, timeline to share data, incentives, or reward to promote data sharing and capacity building for data sharing have remained grey areas in these policy documents. CONCLUSIONS This paper acknowledges the vital role of clinical data sharing from a public health perspective. We found that given the challenges around clinical trial data sharing, developing a feasible mechanism for data sharing is important. We suggest that standardizing data sharing processes by framing a concise policy with key elements of data sharing mechanisms could be easier to practice rather than a rigid and comprehensive data sharing policy. CLINICALTRIAL This scoping review protocol has not been registered and published.

Sign in / Sign up

Export Citation Format

Share Document